Fresh analysis reveals that patients who come off popular slimming jabs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who halt conventional lifestyle programs.
Findings released in a leading health publication points out that while obese people can lose about a fifth of their total mass while undergoing treatment, the mass returns at an estimated rate of nearly a kilo each month once they quit.
"People purchasing these treatments should be informed of the risk of rapid weight regain when the medication concludes," stated expert Dr. Susan Jebb.
This pace of regain implies a return to starting mass in about one and a half years.
Analyzing Approaches
The study, which examined dozens of studies involving thousands of patients, compared the results of the injectable medications with other pills.
Scientists point out that people who shed pounds through lifestyle changes alone typically have a more gradual weight regain—around 0.1 kg a month—once they finish.
The Reason for the Rapid Rebound
Experts propose the way of the drugs is key to understanding the amplified rebound.
The injections mimic a natural hormone called GLP-1, which moderates hunger.
"Sustained high doses of GLP-1 levels far above than the body's typical production might result in the body to produce less of its own natural hormone, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.
"Withdrawal of this GLP-1 'fix' results in hunger is uncontrolled, making overeating much more probable."
A Lifelong Condition?
Health authorities advise the injections for people with obesity-related medical conditions, alongside prescribed lifestyle changes.
Many experts contend that, given the high risk of relapse, the therapy should be considered life-long.
This view is supported by drug manufacturers, who say that the findings "underscore the persistent character of excess weight," comparing it to managing conditions like hypertension.
Patient Accounts
Individuals who have discontinued the jabs report a sudden return of cravings.
"It felt as if a switch that goes on and I was suddenly ravenous," said a patient.
The struggle is exacerbated if users have not established lasting lifestyle or habit changes during treatment.
Widespread Adoption
Survey data show that a significant number of adults in the UK have used these injections in the last 12 months, with demand remaining high.
- Use is more common among females compared to males.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion access the medications through private prescriptions rather than public health services.
In conclusion, clinicians caution that while the jabs are powerful tools for weight loss, they are not a permanent fix and maintained weight loss hinges on integrated behavioural management.
